Historically, dietitians played a minor part in the management of inflammatory bowel disease
(IBD), including Crohn's disease and ulcerative colitis. Patients were commonly referred for …

Importance Irritable bowel syndrome (IBS) affects 7% to 21% of the general population. It is
a chronic condition that can substantially reduce quality of life and work productivity …

Food is often considered to be a precipitating factor of irritable bowel syndrome (IBS)
symptoms. In recent years, there has been a growing interest in FODMAPs (Fermentable …

Irritable bowel syndrome (IBS) is a chronic and debilitating functional gastrointestinal
disorder that affects 9%-23% of the population across the world. The percentage of patients …

Background Irritable bowel syndrome (IBS) is a chronic functional disorder of the
gastrointestinal system affecting a large number of people worldwide. Whilst it has no …

Objectives: Irritable bowel syndrome (IBS) is viewed as a diagnosis of exclusion by most
providers. The aim of our study was to perform a systematic review and meta-analysis to …

Background Functional gastrointestinal symptoms such as abdominal pain, bloating,
distension, constipation, diarrhea and flatulence have been noted in patients with irritable …

Background Placebo treatment can significantly influence subjective symptoms. However, it
is widely believed that response to placebo requires concealment or deception. We tested …

Despite years of advising patients to alter their dietary and supplementary fiber intake, the
evidence surrounding the use of fiber for functional bowel disease is limited. This paper …

Background Dietary fibre supplements have been advocated for the management of chronic
constipation (CC) and irritable bowel syndrome (IBS). Recently, a fermentable …